Goodwill of Oncotelic Therapeutics, Inc. from 30 Apr 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Oncotelic Therapeutics, Inc. quarterly Goodwill in USD history and change rate from 30 Apr 2019 to 30 Sep 2025.
  • Oncotelic Therapeutics, Inc. Goodwill for the quarter ending 30 Sep 2025 was $2,788,230, unchanged year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Oncotelic Therapeutics, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,788,230 $0 0% 30 Sep 2025 10-Q 17 Nov 2025 2025 Q3
Q2 2025 $2,788,230 -$3,200,000 -53% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $2,788,230 -$3,200,000 -53% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $2,788,230 -$3,200,000 -53% 31 Dec 2024 10-Q 17 Nov 2025 2025 Q3
Q3 2024 $2,788,230 -$3,200,000 -53% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 $5,988,230 $0 0% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $5,988,230 -$6,083,146 -50% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $5,988,230 -$6,083,146 -50% 31 Dec 2023 10-Q 17 Nov 2025 2025 Q3
Q3 2023 $5,988,230 -$10,194,227 -63% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $5,988,230 -$10,194,227 -63% 30 Jun 2023 10-Q 18 Aug 2023 2023 Q2
Q1 2023 $12,071,376 -$8,991,079 -43% 31 Mar 2023 10-Q 22 May 2023 2023 Q1
Q4 2022 $12,071,376 -$8,991,079 -43% 31 Dec 2022 10-K 15 Apr 2025 2024 FY
Q3 2022 $16,182,457 -$4,879,998 -23% 30 Sep 2022 10-Q 18 Nov 2022 2022 Q3
Q2 2022 $16,182,457 -$4,879,998 -23% 30 Jun 2022 10-Q 22 Aug 2022 2022 Q2
Q1 2022 $21,062,455 +$2 0% 31 Mar 2022 10-Q 23 May 2022 2022 Q1
Q4 2021 $21,062,455 $0 0% 31 Dec 2021 10-K 12 Apr 2024 2023 FY
Q3 2021 $21,062,455 $0 0% 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 $21,062,455 $0 0% 30 Jun 2021 10-Q 20 Aug 2021 2021 Q2
Q1 2021 $21,062,453 -$2 0% 31 Mar 2021 10-Q 24 May 2021 2021 Q1
Q4 2020 $21,062,455 $0 0% 31 Dec 2020 10-K/A 20 Apr 2023 2022 FY
Q3 2020 $21,062,455 +$16,311,400 +343% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $21,062,455 +$16,311,400 +343% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $21,062,455 +$16,162,455 +330% 31 Mar 2020 10-Q 29 Jun 2020 2020 Q1
Q4 2019 $21,062,455 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q3 2019 $4,751,055 30 Sep 2019 10-Q 19 Nov 2019 2019 Q3
Q2 2019 $4,751,055 30 Jun 2019 10-Q 19 Aug 2019 2019 Q2
Q1 2019 $4,900,000 30 Apr 2019 10-Q 14 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.